Last reviewed · How we verify
NCT07222813
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
NA trial testing FibroScan in Heart Failure in 149 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | Echosens |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 149 |
| Start date | 15 January 2026 |
| Primary completion | 31 December 2026 |
| Estimated completion | 15 January 2027 |
| Sites | 7 locations across France, United States, Germany, Poland |
Drugs / interventions tested
- FibroScan
- Right-sided Heart Catheterization
- Transthoracic echocardiography
- Blood Sample Analysis — full drug profile →
Conditions studied
- Heart Failure — all drugs for Heart Failure →
- Heart Failure - NYHA II - IV — all drugs for Heart Failure - NYHA II - IV →
Sponsor
Echosens — full company profile →
Who can join
18 and older, any sex, with Heart Failure or Heart Failure - NYHA II - IV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07222813
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FibroScan
Trials testing the same drug.
- NCT06592820 — Endoscopic Ultrasound Shear Wave Elastography Study · recruiting
- NCT06877026 — FibroScan-Reproducibility and Repeatability Study · NA · completed
- NCT06328452 — Risk Factors and Impact MASLD in Patients With IBD · unknown
- NCT06445361 — Prevalence of NAFLD in T1DM Patients · NA · recruiting
- NCT07146815 — PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease · NA · completed
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Echosens trials
Trials by the same sponsor.
- NCT07400289 — Development of a FibroScan Liver Examination Using a Single Probe · NA · recruiting
- NCT06877026 — FibroScan-Reproducibility and Repeatability Study · NA · completed
- NCT06519331 — Development of a New Method for Liver Stiffness Measurement Using FibroScan · NA · recruiting
- NCT05567328 — Validation of the New Vibration-guided FibroScan Examination · NA · completed
- NCT05122416 — Optimization of Spleen VCTE Examinations with FibroScan · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07222813 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Echosens
- Last refreshed: 30 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07222813.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing